All Stories

  1. Identifying the 'accomplice' that helps oral cancer spread

    Article • PLoS Genetics, September 2025, PLOS

    Ken Furudate

  2. Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

    Article • Nature Genetics, August 2025, Springer Science + Business Media

    Ken Furudate

  3. Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

    Article • Nature Genetics, July 2025, Springer Science + Business Media

    Ken Furudate

  4. Exploring the immune environment of glioblastoma through single-cell RNA sequencing in humanized mouse models

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Ken Furudate

  5. Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab

    Article • Journal of Hematology & Oncology, May 2025, Springer Science + Business Media

    Ken Furudate

  6. Prenatal Chemotherapy and Its Impact on the Genome of Fetal Hematopoiesis

    Article • Cancer Discovery, May 2025, American Association for Cancer Research (AACR)

    Ken Furudate

  7. CLL cell-derived exosomes alter the immune and hematopoietic systems

    Article • Leukemia, April 2025, Springer Science + Business Media

    Ken Furudate

  8. Utility of lymphocyte-to-monocyte ratio and pretreatment tooth extraction in intra-arterial chemoradiotherapy for oral cancer to prevent osteoradionecrosis of the jaw

    Article • Scientific Reports, December 2024, Springer Science + Business Media

    Ken Furudate

  9. Clonal evolution of hematopoietic stem cells after cancer chemotherapy

    Article • May 2024, Cold Spring Harbor Laboratory Press

    Ken Furudate

  10. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

    Article • Leukemia, March 2024, Springer Science + Business Media

    Ken Furudate

  11. Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma

    Article • Nature Communications, February 2024, Springer Science + Business Media

    Ken Furudate

  12. Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

    Article • November 2023, Springer Science + Business Media

    Ken Furudate

  13. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms

    Article • Blood, October 2022, American Society of Hematology

    Ken Furudate

  14. Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment

    Article • American Journal of Hematology, September 2022, Wiley

    Ken Furudate

  15. Early unilateral rheumatoid arthritis of temporomandibular joint as the only site: A case report and literature review

    Article • Journal of Oral and Maxillofacial Surgery Medicine and Pathology, July 2022, Elsevier

    Ken Furudate

  16. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

    Article • Nature Communications, May 2022, Springer Science + Business Media

    Ken Furudate

  17. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study

    Article • The Lancet Haematology, May 2022, Elsevier

    Ken Furudate

  18. Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib

    Article • Leukemia, April 2022, Springer Science + Business Media

    Ken Furudate

  19. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

    Article • BMC Cancer, April 2022, Springer Science + Business Media

    Ken Furudate

  20. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib

    Article • Leukemia, February 2022, Springer Science + Business Media

    Ken Furudate

  21. Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant

    Article • British Journal of Pharmacology, January 2022, Springer Science + Business Media

    Ken Furudate

  22. Enhanced Spatial Colocalization and Communication of Oral Squamous Cell Carcinoma and Stromal Fibroblasts in Patients with Lymph Node Metastasis

    Article • SSRN Electronic Journal, January 2022, Elsevier

    Ken Furudate

  23. Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia

    Article • Blood, November 2021, American Society of Hematology

    Ken Furudate

  24. Outcomes of TP53 ‐mutant acute myeloid leukemia with decitabine and venetoclax

    Article • Cancer, July 2021, Wiley

    Ken Furudate

  25. Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    Article • Nature Communications, May 2021, Springer Science + Business Media

    Ken Furudate

  26. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

    Article • Nature Communications, May 2021, Springer Science + Business Media

    Ken Furudate

  27. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax

    Article • Blood Advances, April 2021, American Society of Hematology

    Ken Furudate

  28. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia

    Article • British Journal of Haematology, February 2021, Wiley

    Ken Furudate

  29. Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    Article • Nature Communications, November 2020, Springer Science + Business Media

    Ken Furudate

  30. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Ken Furudate

  31. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

    Article • Nature Communications, October 2020, Springer Science + Business Media

    Ken Furudate

  32. Falls Due to Loss of Consciousness are Associated With Maxillofacial Fracture Severity

    Article • Journal of Oral and Maxillofacial Surgery, March 2020, Elsevier

    Ken Furudate

  33. Home visits by occupational therapists in acute hospital care: a systematic review

    Article • International Journal of Rehabilitation Research, September 2019, Wolters Kluwer Health

    Ken Furudate

  34. Conclusiveness of Cochrane Reviews in physiotherapy: a systematic search and analytical review

    Article • International Journal of Rehabilitation Research, June 2019, Wolters Kluwer Health

    Ken Furudate

  35. Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review

    Article • Journal of Oral and Maxillofacial Surgery, January 2018, Elsevier

    Ken Furudate

  36. Oral‐maxillofacial trauma of a geriatric population in a super‐ageing country

    Article • Dental Traumatology, September 2017, Wiley

    Ken Furudate

  37. Localized AL amyloidosis of the tongue: A case report and literature review

    Article • Journal of Oral and Maxillofacial Surgery Medicine and Pathology, March 2017, Elsevier

    Ken Furudate

  38. Impalement of an unusual foreign body on the temporomandibular joint causing severe trismus

    Article • Dental Traumatology, July 2016, Wiley

    Ken Furudate

  39. Retinoic acid-inducible gene-I-like receptor (RLR)-mediated antiviral innate immune responses in the lower respiratory tract: Roles of TRAF3 and TRAF5

    Article • Biochemical and Biophysical Research Communications, November 2015, Elsevier

    Ken Furudate

  40. Identification of a point mutation in the SH3BP2 gene in cherubism

    Article • Journal of Oral and Maxillofacial Surgery Medicine and Pathology, November 2015, Elsevier

    Ken Furudate

  41. Sjögren's syndrome with marked swelling of major salivary glands related to localized AL amyloidosis: A case report and literature review

    Article • Journal of Oral and Maxillofacial Surgery Medicine and Pathology, July 2015, Elsevier

    Ken Furudate

  42. Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer

    Article • Supportive Care in Cancer, May 2015, Springer Science + Business Media

    Ken Furudate

  43. Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic–polycytidylic acid in U373MG human astrocytoma cells

    Article • Neuroscience Research, May 2015, Elsevier

    Professor Hiroshi Tanaka, Ken Furudate

  44. A case of congenital ranula: The importance of timely and precise treatment

    Article • Journal of Oral and Maxillofacial Surgery Medicine and Pathology, May 2015, Elsevier

    Ken Furudate

  45. Transition of instruments in The SINE WAVE ORCHESTRA

    Article • Computers in Entertainment, December 2008, ACM (Association for Computing Machinery)

    Ken Furudate

  46. The SINE WAVE ORCHESTRA stay

    Article • November 2005, ACM (Association for Computing Machinery)

    Ken Furudate